|
Volumn 295, Issue 5557, 2002, Pages 975-
|
Some history should be repeated
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALTEPLASE;
ETANERCEPT;
HEPATITIS B VACCINE;
INFLIXIMAB;
INSULIN ASPART;
INSULIN GLARGINE;
INSULIN LISPRO;
RECOMBINANT ALPHA2B INTERFERON;
RECOMBINANT DNA;
RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;
RETEPLASE;
TENECTEPLASE;
HISTORY;
ACUTE HEART INFARCTION;
BIOTECHNOLOGY;
CELL NUCLEUS TRANSPLANTATION;
DIABETES MELLITUS;
HEPATITIS B;
HUMAN;
MEDICAL GENETICS;
MOLECULAR CLONING;
POLITICS;
PRIORITY JOURNAL;
RECOMBINANT DNA TECHNOLOGY;
RHEUMATOID ARTHRITIS;
SHORT SURVEY;
SOMATIC CELL;
STROKE;
ANIMAL;
ARTICLE;
BIOETHICS;
CLONING;
CYTOLOGY;
EMBRYO;
INFERTILITY THERAPY;
LEGAL ASPECT;
RESEARCH;
STEM CELL;
UNITED STATES;
ANIMALS;
BIOETHICAL ISSUES;
BIOTECHNOLOGY;
CLONING, ORGANISM;
DNA, RECOMBINANT;
EMBRYO;
HUMANS;
REPRODUCTIVE TECHNIQUES, ASSISTED;
RESEARCH;
STEM CELLS;
UNITED STATES;
|
EID: 0037039871
PISSN: 00368075
EISSN: None
Source Type: Journal
DOI: 10.1126/science.1069614 Document Type: Short Survey |
Times cited : (9)
|
References (0)
|